Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Arun Viswanathan
Period: Reporting periods mapped to calendar 2024 Q4 – 2026 Q2 (7 quarters).
- Questions
- 59on tracked calls
- Challenge rate
- 7%4 of 59 questions
- Companies
- 10questioned at least once
- Reporting periods
- 7with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 59 of 59 questions from 10 companies
BALLBall Corporation12 questions · 6 reporting periods · 0 of 12 challenging
Calendar 2026 Q1
would you be adding more capacity? And what are your customers, I guess, when you do go through this process, you kind of presell the plant out
Show response
Lewis confirmed Millersburg comes on back of long-term offtake agreement with strategic customer. Potential North Carolina East Coast plant before end of decade for energy drink customer growth, but not imminent. All capacity investments require pre-sold customer commitment.
given that tight capacity, would there be any pricing opportunities over the next few years
Show response
Lewis described mid-to-high-90s utilization across regions. Contract turnover significantly less than one-third annually given long-term nature. Pricing opportunities exist for value-added services (specialty cans, promotions, different inks) rather than commodity pricing.
Calendar 2025 Q4
do you see the energy market kind of continuing to outpace the rest of the can market
Show response
Lewis described customers evolving into total beverage companies regardless of origin. Energy continues innovating in sizes, functional elements, and formats. Expects energy to keep winning.
how are you managing through that? And then also the rising aluminum price environment, what are your customers saying there
Show response
Lewis noted no direct business impact beyond ends domestication. Midwest premium spike is the main aluminum-related pressure. Cans grew 2% while other substrates declined 2%+ in 2025, reinforcing can as value vehicle.
Calendar 2025 Q3
Do you see energy continuing to grow next year at a similar pace on tougher comps
Show response
Fisher cited non-alc 52-week growth of 4.8% vs alcohol decline of 2.5%. Highlighted health/wellness and protein innovation as untapped can opportunities. Ball repositioning portfolio toward winning categories for 2027+ step-change growth.
was there anything on working capital or cash tax or minority interest or anything else that would drag cash flow
Show response
Rabbitt indicated no unusual cash items expected for 2026 and current favorable trends should continue.
would there be any issues on metal supply that we should consider
Show response
Fisher noted one supplier's issue (8% of NA can sheet market, primarily automotive) was managed effectively. US still short on processed aluminum, but Novelis and SDI new facilities coming in next few years. May need low-capital footprint adjustments for tariff scenarios.
Calendar 2025 Q2
maybe you can just discuss your thoughts on returning that 2:1 kind of EBIT leverage on top line growth
Show response
Fisher noted $60M of non-repeating headwinds (interest income loss + insurance proceeds). Excluding those, enterprise 2:1 leverage intact. Repositioning portfolio from 40% to 30% beer mix.
Calendar 2025 Q1
How long are your contracts now? Are they still kind of maybe in the year or so level? What's your visibility on the volumes over the next few quarters
Show response
Fisher emphasized contracting for medium-term visibility, supplemented by scanner data and customer inventory analysis for quarterly views. Florida Can running full in peak season.
would you say your outperformance from on the segment EBIT perspective was kind of equally split between slight volume outperformance, price mix and strong execution
Show response
Fisher attributed outperformance primarily to favorable mix and modest operational efficiency, with volume roughly offsetting inflationary pressures.
Calendar 2024 Q4
what is it really going to take for them to accelerate beer, because as you said earlier and throughout the call that if you're not growing very globally
Show response
Fisher framed beer companies as needing to evolve into broader beverage companies. Innovation in non-alcohol, ready-to-drink, and portfolio optimization key. Can format remains favored.
Could you provide maybe your thoughts on ROIC or payback period, if there's any synergies? What can those two can add to your outlook
Show response
Fisher quantified Florida acquisition at $25-35M EBITDA run rate by 2027 with four-year positive EVA payback. Oregon serves existing demand currently shipped cross-country.
ALBAlbemarle Corporation9 questions · 5 reporting periods · 1 of 9 challenging
Calendar 2026 Q2
do you expect to grow volumes next year and maybe kind of in the low single-digit range?
Show response
Kent guided roughly flat volumes this year (fire offset by Wodgina) with high-single-digit growth in 2027 as CGP3 ramps; Neal framed 2027 at 240,000 to 260,000 tons LCE.
Calendar 2026 Q1
did you discuss the reduction of output at Greenbushes? It looks like it's about 10% to 15%, and how that affects kind of your own operations?
Show response
Masters reiterated Greenbushes is on their risk-adjusted plan for the year. CGP3 ramp started with first ore in late 2025, expected at full capacity by year-end, on schedule.
I think you're still guiding to about flattish volumes. So is there any way you can address that upside on demand, if there is any?
Show response
Masters said the volume constraint is product availability, not demand. Norris added that battery company order books are full through beginning of 2027. Sheorey noted volume growth depends on CGP3 ramp and Wodgina capacity improvements.
Calendar 2025 Q3
could you also comment on your potential commercialization in the energy storage market?
Show response
Masters said grid storage is driven by renewables + storage mandates and AI/data center demand. Expects ~80% of ESS to remain lithium-ion with sodium entering long-term.
Would it take spodumene maybe to go up to $1,200 or $1,500 to see some more robust activity in lithium salt pricing?
Show response
Masters confirmed conversion is at marginal cost with all upside value flowing to spodumene. Market is tightening, a demand story with inventories declining across the system.
Calendar 2025 Q2
It looks like midpoint of your scenarios still about $900 million, which kind of implies a pretty low EBITDA level for the second half
Show response
Sheorey explained it's primarily a mix effect from heavier contract demand in H1, plus lower lithium prices offset by cost savings and plant ramps.
How much of capacity to say, uneconomic? And are there any further comments on inventory levels
Show response
Masters declined to speculate on specific shutdowns but identified single-asset companies and cash-negative startups as most vulnerable.
Calendar 2025 Q1
do you expect some similar curtailments this year as you move into the summer?
Show response
Masters acknowledged pressure on high-cost producers but said it's impossible to predict when and if specific assets will curtail.
Could you just discuss maybe some more of your efforts there and or maybe even within the industry? Have you seen any further commercialization there?
Show response
Masters noted grid storage is now nearly 20% of lithium demand and growing faster than EVs. Increasingly driven by grid stability around AI data centers.
DDDuPont7 questions · 4 reporting periods · 0 of 7 challenging
Calendar 2026 Q1
is that really the last kind of accelerated repurchase activity that we should expect?
Show response
Franzen noted $775M of $2B buyback program used ($500M + $275M ASRs). Will continue to evaluate opportunities. Significant flexibility from Aramids proceeds and balance sheet strength.
would you expect -- and maybe you can just provide us an update on the 80/20 strategy within Diversified Industrials
Show response
Koch confirmed 80/20 focused on margin enhancement across 4 initial businesses. Portfolio currently 50/50 Healthcare & Water vs Diversified, targeting 2/3-1/3 over medium term. Has dry powder and Aramids cash for M&A opportunities.
Calendar 2025 Q4
did you also mention maybe M&A across both of those businesses, if there are opportunities
Show response
Koch confirmed active scouting in both spaces with healthcare pipeline deeper (more fragmentation, lower valuations). Med device focus similar to Spectrum/Donatelle, building total solutions offering and application development partnerships.
did you see any destocking there? We did see, you know, maybe one of your competitors within healthcare packaging, reference some of that
Show response
Koch confirmed destocking fully behind in 2025 with normalized inventory levels in both Healthcare and Water heading into 2026.
Calendar 2025 Q3
Could you also comment on the water side you guys recently completed that acquisition in China. What else are you guys looking at
Show response
Koch confirmed water M&A focused on filtration adjacencies and systems/services plays. Metering off the table on valuation. Will bias R&D, capital, and M&A toward Healthcare & Water for outsized returns.
Calendar 2025 Q1
have you seen any change in your order patterns amongst some of the industrial customers, maybe in different countries on the water side?
Show response
Koch confirmed no tariff-driven order disruptions in IndustrialsCo, with April orders tracking to expectations.
is it possible that you could pursue any M&A ahead of the spin? You talked about growth in Healthcare and Water
Show response
Koch confirmed no material M&A before spin, with robust pipeline for post-separation activity on both RemainCo and Qnity sides.
SHWThe Sherwin-Williams Company7 questions · 7 reporting periods · 0 of 7 challenging
Calendar 2026 Q2
I was hoping to ask just on 2 segments, resi repaint and packaging. I think both of those are in the mid single digit
Show response
Petz rejected the plateau framing, calling res repaint the largest remaining share opportunity, and tied packaging strength to beverage cans and the BPA ban.
Calendar 2026 Q1
still very strong, I guess, or relatively solid resi repaint. Do you see that continuing
Show response
Heidi emphatically confirmed continuation, citing Emerald Symmetry launch helping contractor productivity, direct install growing double digits, and protective and marine seventh straight quarter up at least high single digits.
Calendar 2025 Q4
I just wanted to understand the element of potential conservatism in the guide here.
Show response
Ben emphasized 'realistic' framing anchored on low single-digit existing home sales assumption, with upside if rates/existing homes/confidence improve.
Calendar 2025 Q3
Maybe I could get like a little bit of an early read on next year. You do have some share gains coming to you.
Show response
Heidi declined to give 2026 comp guidance; Al deferred to January update after operating plan process completion.
Calendar 2025 Q2
you have made some comments about, softer for longer. So you know, the housing market maybe will should should it settle into maybe a one to three percent growth rate and you could be maybe two tim...
Show response
Al lifted the long-term Paint Stores growth algorithm from historical 1.5-2x to 2.5-3x market, citing 400+ more stores and 500+ more reps since 2019.
Calendar 2025 Q1
how did March shape up and how did April shape up as well?
Show response
Al said April starting in line with Q2 guide; March better than Jan/Feb; Southeast and Southwest divisions at or above overall Paint Stores performance, so weather was not a material drag.
Calendar 2024 Q4
if you think about Q1, obviously impacted by weather, maybe you expect kind of the Q2 to Q4 kind of sales growth to be above Q1 levels
Show response
Al described Q1 as continuation of Q4 choppiness, with res repaint consistent mid-single-digit growth, packaging strength tied to European BPA conversion in first half of 2026, auto refinish improvement on claims annualization, coil wins continuing, industrial wood tied to new res recovery, and general industrial remaining soft throughout 2025.
PPGPPG Industries6 questions · 6 reporting periods · 2 of 6 challenging
Calendar 2026 Q2
Are there any areas that you find are delivering returns below your threshold
Show response
Answered up front that nothing of size is for sale, while conceding a couple of small fringe businesses he would like to clean up.
Calendar 2025 Q4
it looks like you're guiding to about 4% EPS growth. If I back into it, it looks like about 3% EBITDA growth
Show response
Knavish reiterated refinish is #1, #2, #3 reason for muted leverage. Corporate expenses not structurally higher. Once refinish normalizes in H2, leverage will materialize. Morales added headwinds from higher interest costs (low-rate debt rolling off) and slight tax rate increase across jurisdictions.
Calendar 2025 Q3
Are there further actions you can take there maybe to redeploy some of that capital into aerospace and other areas that are growing
Show response
Knavish highlighted portfolio transformation: went from ~15% EBITDA company to ~20% through divestitures (U.S. Arch, Silicas, Russia, Africa exits, Traffic pruning). Nothing needle-moving being worked on now. Morales noted the ~$0.05 YoY EPS decrement from 2025 divestitures masks underlying growth.
Calendar 2025 Q2
is it really production that you'd expect that would drive you further next year? Is there any other initiatives, whether it be EV growth in China or maybe some Europe customer mix?
Show response
Knavish cited short-term share gains plus long-term fundamentals: fleet age deficit, car park per capita growth in India/China, global underproduction since COVID. Morales added customer-specific headwinds from H2 2024 becoming tailwinds in H2 2025, plus China retail up double digits with production lagging.
Calendar 2025 Q1
in Auto OEM, I understand that there's some choppy demand trends right now. But would you say that your customer mix or maybe your mix towards EVs or ICEs would be in any way a mitigating factor?
Show response
Knavish acknowledged customer mix has been a challenge, team working to rebalance via share gains ($100M includes auto OEM). EV outside China is small; inside China, PPG is #1 with the largest player. Refinish Q1 strength driven by share wins and favorable U.S. customer order patterns.
Calendar 2024 Q4
What would you say are some risks that you do see in front of you
Show response
Tim acknowledged geopolitical uncertainty as the main risk but expressed confidence in full-year guide given controllable factors and pipeline strength.
QQnity Electronics, Inc.6 questions · 3 reporting periods · 1 of 6 challenging
Calendar 2026 Q1
you mentioned the growth and the move towards 2, 3-nanometer as well as 12, 14 and 16 [ Angstrom ] technologies
Show response
Kemp confirmed strong POR positions at angstrom-era nodes with sufficient capacity from recent investments. Benefits for both CMP and lithography businesses.
are you still thinking about stronger than mid-single-digit growth in MSI this year?
Show response
Kemp confirmed MSI expectation raised to mid-to-high single digit with room to do better. Data center mix approaching 20% of portfolio. Automotive and aerospace diversification growing.
Calendar 2025 Q4
is there a kind of a framework on how we should think that should play out over the next 3 years
Show response
CFO broke down $100M: ~50% from productivity, ~25% from commercial/innovation, ~25% from local-for-local optimization. Small benefit in 2026 guidance, remainder in 2027-2028.
at the low end, I think you're up about 4.5%. What would be some of the things that would maybe push you towards that end
Show response
CEO identified memory demand destruction as low-end risk; high-end upside from faster customer capacity expansions at advanced nodes. Content growth from node transitions compounds with volume.
Calendar 2025 Q3
your growth was about 7% year-on-year in Q3 ex the onetime event, but your EBITDA growth was in the 6% range year-on-year
Show response
CFO attributed margin lag to ICS segment mix (mid-20s margins vs semi mid-30s), FX headwind, and selective growth investments. CEO reaffirmed confidence in operating leverage going forward.
Do you kind of feel like the capacity there you have is sufficient
Show response
CEO emphasized capacity additions across all semi businesses over past 3-4 years. R&D at 7% of sales and CapEx at 6% provide 13% total reinvestment rate.
Show 4 more companies
CTVACorteva5 questions · 5 reporting periods · 0 of 5 challenging
Calendar 2026 Q2
could you just provide us maybe an updated view on some broad strokes for fiscal 2027.
Show response
Magro said the external backdrop is broadly as expected through 2027, with Corteva running slightly ahead internally on cost, licensing and new products.
Calendar 2026 Q1
Your main competitor has been potentially a little strapped in the last few years, but they do have some new products coming out
Show response
Judd detailed strong pipeline: Z-series soybeans, Enlist at 65%+ penetration, next-gen aboveground traits in 2030 for NA and LatAm, and novel below-ground traits in 2030-2031.
Calendar 2025 Q4
maybe you could break that out between Seed and CP if that's relevant
Show response
Judd said $200M split roughly equally between Seed and CP and represents a running rate with annual opportunities in both. Chuck noted the 2027 framework target of $700M was nearly achieved in 2025 alone, so they will far exceed it by 2027.
Calendar 2025 Q3
do you see continued margin growth as you move into '26? And what will be driving that?
Show response
Chuck confirmed margin journey will continue toward 24% target by 2027. Drivers spread across new products, seed out-licensing, and cost productivity. Net cost trending better than $700M target.
Calendar 2024 Q4
just curious, if that would be kind of similar to what you saw in 2024 or maybe more so in the $300 to $350 million range
Show response
David said EGL proportionate to EBITDA, slightly higher in 2025. Buyback plan remains $1 billion ratably through year. Ended 2024 with $3.1B cash, providing room for tuck-in acquisitions.
APDAir Products3 questions · 2 reporting periods · 0 of 3 challenging
Calendar 2026 Q2
you started the year expecting a 9% EPS growth, you're now guiding to 11%-12%
Show response
Melissa said the raise to 11-12% growth was driven mainly by market volumes (Americas HyCO, Asia electronics green shoots) plus a 3% new-asset benefit, price, and productivity, tempered by macro caution in Asia and Europe.
is there an opportunity to potentially pull forward the buyback capabilities or even potentially pursue some M&A?
Show response
Melissa reiterated disciplined capital deployment: high-return projects and opportunistic M&A first, with buybacks likely coming into line of sight around late 2027/early 2028 as cash positions improve.
Calendar 2025 Q3
Maybe you can just clarify that. And then on the helium headwind for next year, it looks like Q1 is maybe a negative 6%, but then the full year is negative 4%
Show response
Melissa confirmed FY2025 helium at $0.49 (slightly better than $0.50-$0.55 forecast). Q1 FY2026 tough comp due to prior year bulk helium sale. FY2026 CapEx expected $3.5-$4B with limited flexibility given project commitments.
AMCRAmcor2 questions · 2 reporting periods · 0 of 2 challenging
Calendar 2025 Q2
Maybe you can just put that in context. So does that kind of accelerate through the year
Show response
Michael detailed: $240M cost synergies + $20M financial synergies = $260M total. ~$0.09 EPS after tax = 12% baseline growth. Phasing: ~15% in Q1 ($35-40M), ~35% in H1 (~$90M), balance in H2 with strong Q4 exit. 40/40/20 split across FY26/27/28. G&A and procurement dominate year 1.
Calendar 2025 Q1
maybe you can just comment on if that’s something that you see that’s still within the crosshairs for the combined company
Show response
PK acknowledged both companies had low single-digit organic growth historically. Levers for improvement: portfolio pruning, broader product offering, geographic leverage, and combined innovation. Procurement beyond price includes terms harmonization and potential long-term agreements.
LINLinde plc2 questions · 2 reporting periods · 0 of 2 challenging
Calendar 2026 Q2
elaborate a little bit more on some of the actions you are taking to drive a little bit of the margin recovery.
Show response
Matthew cited easier back-half comps, Lincare focus, and planned cost actions this quarter above normal productivity, with more color at the October call.
Calendar 2026 Q1
do you expect FX would continue to play that contribution for the year EPS? And if you do fall short of your 10% goal
Show response
White noted 1% FX tailwind in assumptions with current spot rates better. Helium drag and engineering business timing (~1% drag) need to clear for return to 8-12% ex-macro algo. Will take incremental actions if needed to bridge to double-digit EPS growth.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| BALL Ball Corporation | 12 | 0%none of 12 questions |
| ALB Albemarle Corporation | 9 | 11%1 of 9 questions |
| DD DuPont | 7 | 0%none of 7 questions |
| SHW The Sherwin-Williams Company | 7 | 0%none of 7 questions |
| PPG PPG Industries | 6 | 33%2 of 6 questions |
| Q Qnity Electronics, Inc. | 6 | 17%1 of 6 questions |
| CTVA Corteva | 5 | 0%none of 5 questions |
| APD Air Products | 3 | 0%none of 3 questions |
| AMCR Amcor | 2 | —Rate withheld: fewer than 3 questions |
| LIN Linde plc | 2 | —Rate withheld: fewer than 3 questions |
- BALLBall Corporation · 12 questions0%none of 12 questions
- ALBAlbemarle Corporation · 9 questions11%1 of 9 questions
- DDDuPont · 7 questions0%none of 7 questions
- SHWThe Sherwin-Williams Company · 7 questions0%none of 7 questions
- PPGPPG Industries · 6 questions33%2 of 6 questions
- QQnity Electronics, Inc. · 6 questions17%1 of 6 questions
- CTVACorteva · 5 questions0%none of 5 questions
- APDAir Products · 3 questions0%none of 3 questions
- AMCRAmcor · 2 questions—rate withheld: under 3 questions
- LINLinde plc · 2 questions—rate withheld: under 3 questions
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2024 Q4 | 5 | 20%1 of 5 questions | 4 |
| 2025 Q1 | 9 | 0%none of 9 questions | 6 |
| 2025 Q2 | 6 | 17%1 of 6 questions | 5 |
| 2025 Q3 | 12 | 8%1 of 12 questions | 8 |
| 2025 Q4 | 9 | 11%1 of 9 questions | 6 |
| 2026 Q1 | 11 | 0%none of 11 questions | 7 |
| 2026 Q2 | 7 | 0%none of 7 questions | 6 |
- 2024 Q45 questions · challenge rate 20% (1 of 5 questions) · 4 companies
- 2025 Q19 questions · challenge rate 0% (none of 9 questions) · 6 companies
- 2025 Q26 questions · challenge rate 17% (1 of 6 questions) · 5 companies
- 2025 Q312 questions · challenge rate 8% (1 of 12 questions) · 8 companies
- 2025 Q49 questions · challenge rate 11% (1 of 9 questions) · 6 companies
- 2026 Q111 questions · challenge rate 0% (none of 11 questions) · 7 companies
- 2026 Q27 questions · challenge rate 0% (none of 7 questions) · 6 companies
Topics
Topics tagged on this analyst’s questions.
- Demand20
- Competitive Dynamics14
- Revenue Growth11
- Guidance Reliability10
- Margin10
- M&A9
- Capital Allocation8
- Capex Investment7
- Supply Chain6
- Cost Pressure5
Show all 17 topics
- Pricing4
- Innovation & R&D4
- Trade Tariffs3
- Macroeconomic2
- Fx2
- Cloud & AI2
- Inventory1